Lyme disease vaccine acceptability among healthcare providers ― United States, 2018 and 2022
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
This publication has 20 references indexed in Scilit:
- Parental knowledge and attitudes to infant immunization in the context of RSV: All about confidence?Vaccine, 2024
- Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studiesThe Lancet Infectious Diseases, 2024
- Impact of the COVID-19 pandemic on routine childhood vaccination in 9 U.S. jurisdictionsVaccine, 2024
- Lyme disease vaccine attitudes and intentions among parents of children aged 5–18 years in the United StatesVaccine, 2024
- Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemicnpj Vaccines, 2024
- Development of an mRNA-lipid nanoparticle vaccine against Lyme diseaseMolecular Therapy, 2023
- Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United StatesVaccine, 2022
- Vaccine hesitancy and healthcare providersVaccine, 2016
- Provider communication about HPV vaccination: A systematic reviewHuman Vaccines & Immunotherapeutics, 2016
- The Lyme vaccine: a cautionary taleEpidemiology and Infection, 2006